ArticlePloS one2022

Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.

Stephen Clarke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.